Brian Kirwan Email & Phone Number

Cambridge, Ma

Hired to create the Commercial Finance function and lead the FP&A team as the company moves toward commercializing its first asset.

Cambridge, Massachusetts, United States

Hired as company’s second commercial employee to design, build and lead the Market Access functions for the company’s emerging portfolio of microbiome products. Primarily focused on the near-term launch plan for Phase 3 microbiome product for C. Difficile infection, and strategic planning for Phase 2 microbiome product for ulcerative colitis. After Seres entered into co-commercialization agreement with Nestle, I was asked to join the Finance organization to work with the CFO to help build the Finance organization to support Seres’ growth and eventual transition to a commercial enterprise, while maintaining support for the Chief Commercial Officer and the Commercial organization in Market Access planning and execution. • Led all launch planning and commercial development activities for Market Access, including payer and pricing research, and the design of the distribution model and patient support services prior to the Nestle agreement. • Accountable for the health economics and outcomes research supporting VOWST’s value proposition and economic modelling.• Outlined the payer engagement plan from pre-launch through the launch window, including cross-functional alignment with Medical Affairs’ Medical Science Liaisons.• Built Launch Readiness Plan for all Market Access functions for Phase 3 asset approaching commercialization, as well as the initial Gross to Net forecasts for both late stage assets. • Dedicated and loyal organizational leader that accepted a stretch leadership assignment to establish the ‘Finance & Operations’ team when the organization needed my commercial and financial experience in the Finance organization• Served in leadership roles on the Joint Commercial Committee working across the co-commercialization partnership on launch planning and execution for VOWST.• Supported the Chief Financial Officer in obtaining both debt and equity financing during my time in my Finance role.

Redwood City, California, United States

**Menlo Therapeutics merged into Foamix in March 2020 and became Vyne Therapeutics**I joined Menlo Therapeutics as company’s second commercial employee to design, build and lead the Market Access functions for the company’s first product, serlopitant. Led all launch planning and commercial development activities for Market Access, and partnered with the head of Commercial Development on all aspects of the organization design and commercialization needs. Worked with Foamix colleagues to transition all launch plans and research to the new organization.

Redwood City, California, United States

Led a team of 40 home office and customer facing field professionals in the dynamic market access environment, accountable for payer strategy, tactics, and field operations, development and management of patient support services, customer facing reimbursement and logistical access support for physicians and office staff, all strategic pricing, contract management and government reporting activities, and ownership of the forward aspects of the supply chain including third party logistics, trade, distribution, and pharmacy.

Established and led all pricing functions in the US, including setting the initial launch WAC, establishing the organization's pricing governance process, and determining overall discount/net pricing approach for individual payer segments and entities.Led all channel/trade strategy and operating activities for the Company in the US, including product flow, interactions and relationships with pharmacies and wholesale distributors, and implementation and management of product distribution and the third party logistics provider. Accountable for government pricing and reporting, and contract management and operations for all market access contracts (trade/channel/payer.)

•Lead a team of eight professionals who develop and implement trade distribution strategy, translate strategy into actionable tactics and contracts, negotiate and manage channel partner (both national and regional accounts) contracts, manage the day- to- day enactment of the contracts through inventory operations and analytics, and manage overall channel performance through review of contract data and supporting documentation. •Role includes developing the channel and distribution approach for GlaxoSmithKline’s pharmaceutical, oncology (oral and infused), biopharmaceutical and vaccine products in the United States from launch to harvest.

Bachelor Of Science (Bs), Accounting, Magna Cum Laude

Activities and Societies: University Honor Society; Beta Gamma Sigma; Varsity Soccer; LEADERS volunteer program

Mba, Management, With Highest Honors

Executive Scholars Program, Marketing And Sales Management

Executive Certificate Program